Page 103 - Demo

Parkinsonism in GNDs101217. Foo JN, Lee J, Tan LC, Liu J, Tan EK. Large 3-Mb deletions at 22q11.2 locus in Parkinson’s disease and schizophrenia. Mov Disord. Dec 2016;31(12):1924-1925. doi:10.1002/mds.2682218. Clayton PT, Smith I, Harding B. Subacute combined degeneration of the cord, dementia and Parkinsonism due to an inborn error of folate metabolism. Journal of Neurology Neurosurgery and Psychiatry. 1986;49(8):920-927. 19. Fan SP, Lee NC, Lin CH. Novel Phenotype of 6p25 Deletion Syndrome Presenting Juvenile Parkinsonism and Brain Calcification. Mov Disord. May 5 2020;doi:10.1002/mds.2807920. Park J, Park ST, Kim J, Kwon KY. A case report of adult-onset Alexander disease clinically presenting as Parkinson’s disease: is the comorbidity associated with genetic susceptibility? BMC Neurol. Jan 17 2020;20(1):27. doi:10.1186/s12883-020-1616-821. Sechi GP, Conti M, Sau GF, Cocco GA. Valproate-induced parkinsonism, glial cells and Alexander’s disease. Prog Neuropsychopharmacol Biol Psychiatry. Jul 1 2008;32(5):1351-2. doi:10.1016/j.pnpbp.2008.03.02222. Vazquez-Justes D, Penalva-Garcia J, Lopez R, Mitjana R, Begue R, Gonzalez-Mingot C. Parkinsonism phenotype in a family with adult onset Alexander disease and a novel mutation of GFAP. Clin Neurol Neurosurg. May 6 2020;195:105893. doi:10.1016/j.clineuro.2020.10589323. Yoshida T, Sasayama H, Mizuta I, et al. Glial fibrillary acidic protein mutations in adult-onsetAlexander disease: clinical features observed in 12 Japanese patients. Acta Neurol Scand. Aug 2011;124(2):104-8. doi:10.1111/j.1600-0404.2010.01427.x24. Harbord M. Levodopa responsive Parkinsonism in adults with Angelman Syndrome. J Clin Neurosci. Sep 2001;8(5):421-2. doi:10.1054/jocn.2000.075325. Woodward K, Bhatti D, Rush E. First reported case of parkinsonism in a patient with argininosuccinate lyase deficiency. Movement Disorders. 2017;32(Supplement 2):703-704. 21st International Congress of Parkinson’s Disease and Movement Disorders. Canada. doi:http://dx.doi.org/10.1002/mds.2708726. Akcakaya NH, Salman B, Gormez Z, et al. A Novel and Mosaic WDR45 Nonsense Variant Causes Beta-Propeller Protein-Associated Neurodegeneration Identified Through WholeExome Sequencing and X chromosome Heterozygosity Analysis. Neuromolecular Med. Mar 2019;21(1):54-59. doi:10.1007/s12017-018-08522-627. Hornemann F, Le Duc D, Roth C, Pfaffle R, Huhle D, Merkenschlager A. Childhood DystoniaParkinsonism Following Infantile Spasms-Clinical Clue to Diagnosis in Early BetaPropeller Protein-Associated Neurodegeneration. Neuropediatrics. Feb 2020;51(1):22-29. doi:10.1055/s-0039-169668828. Kumada S, Hayakawa I, Nakata Y, et al. A functional neuroradiological study in an adult case of betapropeller protein-associated neurodegeneration. Movement Disorders. 2015;30(SUPPL. 1):S384-S385. 19th International Congress of Parkinson’s Disease and Movement Disorders. San Diego, CA United States.(var.pagings). doi:http://dx.doi.org/10.1002/mds.2629529. Machado D. Genetic testing for beta-propeller protein-associated neurodegeneration (BPAN). Neurology. 2017;88(16 Supplement 1)69th American Academy of Neurology Annual Meeting, AAN 2017. United States. 30. Ohi K, Kageyama Y, Ichikawa K, Nishioka K. Clinical investigation of beta-propeller protein associated neurogeneration (BPAN). Journal of the Neurological Sciences. 2017;381(Supplement 1):701-702. 23rd World Congress of Neurology, WCN 2017. Japan. doi:http://dx.doi.org/10.1016/j.jns.2017.08.197531. Fonderico M, Laudisi M, Andreasi NG, et al. Patient Affected by Beta-Propeller ProteinAssociated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy. Front Neurol. 2017;8:385. doi:10.3389/fneur.2017.0038532. Ichinose Y, Miwa M, Onohara A, et al. Characteristic MRI findings in beta-propellerprotein-associated neurodegeneration (BPAN). Neurol Clin Pract. Apr 2014;4(2):175-177. doi:10.1212/01.CPJ.0000437694.17888.9b33. Verhoeven WM, Egger JI, Koolen DA, et al. Beta-propeller protein-associated neurodegeneration (BPAN), a rare form of NBIA: novel mutations and neuropsychiatric phenotype in three adult patients. Parkinsonism Relat Disord. Mar 2014;20(3):332-6. doi:10.1016/j.parkreldis.2013.11.01934. Zhang L, Malhado-Chang N, Shankar S, Hagerman R. Autistic parkinsonism: NBIA with mosaic WDR45 mutation and datscan positive dopa-responsiveness. Neurology. 2019;92(15